What is the relationship between Lp(a) and ASCVD risk?
Lp(a) increases ASCVD risk especially at higher levels. Thus, if a decision is made to measure Lp(a), an Lp(a) 50 mg/dL or 125 nmol/L, Lp(a) may be considered a risk-enhancing factor. In the present document, an elevation of Lp(a) is considered to be a risk-enhancing factor, especially in those with higher Lp(a) values and, if used in women, only in the presence of hypercholesterolemia.